Showing results (11-20 of 349) with videos related to
Sort By:
Pageof 35
Current Opinion in Oncology|January 1, 2005
Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancerAndrew M EvensHematological Oncology|June 15, 2025
Newly Diagnosed Classical Hodgkin Lymphoma: Optimizing Outcomes in a New Therapeutic EraAndrew M EvensBlood|November 28, 2014
The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage diseaseAndrew M Evens, Lale KostakogluHematology. American Society of Hematology. Education Program|February 20, 2015
The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage diseaseAndrew M Evens, Lale KostakogluCurrent Opinion in Oncology|May 25, 2006
Targeting angiogenesis for the treatment of sarcomaLakshmi Balasubramanian, Andrew M EvensPsychopathology|January 1, 1987
Affect recognition and self-esteem in schizophreniaD A Garfield, M L Rogoff, S SteinbergClinical Advances in Hematology & Oncology : H&O|July 8, 2014
FDG-PET imaging for Hodgkin lymphoma: current use and future applicationsLale Kostakoglu, Andrew M EvensBiological Psychiatry|February 10, 1999
Lupron-induced maniaM Rachman, D A Garfield, I Rachman, et al.Clinical Lymphoma|October 23, 2004
Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyondAndrew M Evens, Leo I GordonFrontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Molecular etiology of mature T-cell non-Hodgkin's lymphomasAndrew M Evens, Ronald B GartenhausPageof 35